vs
Side-by-side financial comparison of Enovis CORP (ENOV) and SMITH & NEPHEW PLC (SNN). Click either name above to swap in a different company.
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $548.9M | — | ||
| Q3 25 | $564.5M | — | ||
| Q2 25 | $558.8M | — | ||
| Q4 24 | $561.0M | — | ||
| Q3 24 | $505.2M | — | ||
| Q2 24 | $525.2M | — | ||
| Q1 24 | $516.3M | — | ||
| Q4 23 | $455.0M | — |
| Q4 25 | $-571.1M | — | ||
| Q3 25 | $-36.7M | — | ||
| Q2 25 | $-56.0M | — | ||
| Q4 24 | $-703.2M | — | ||
| Q3 24 | $-31.5M | — | ||
| Q2 24 | $-18.6M | — | ||
| Q1 24 | $-72.0M | — | ||
| Q4 23 | $3.1M | — |
| Q4 25 | 59.9% | — | ||
| Q3 25 | 59.3% | — | ||
| Q2 25 | 59.5% | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 56.7% | — | ||
| Q2 24 | 55.0% | — | ||
| Q1 24 | 57.7% | — | ||
| Q4 23 | 58.1% | — |
| Q4 25 | -101.7% | — | ||
| Q3 25 | -3.0% | — | ||
| Q2 25 | -8.4% | — | ||
| Q4 24 | -118.5% | — | ||
| Q3 24 | -6.3% | — | ||
| Q2 24 | -8.4% | — | ||
| Q1 24 | -6.8% | — | ||
| Q4 23 | -1.3% | — |
| Q4 25 | -104.1% | — | ||
| Q3 25 | -6.5% | — | ||
| Q2 25 | -10.0% | — | ||
| Q4 24 | -125.4% | — | ||
| Q3 24 | -6.2% | — | ||
| Q2 24 | -3.5% | — | ||
| Q1 24 | -13.9% | — | ||
| Q4 23 | 0.7% | — |
| Q4 25 | $-9.99 | — | ||
| Q3 25 | $-0.64 | — | ||
| Q2 25 | $-0.98 | — | ||
| Q4 24 | $-12.69 | — | ||
| Q3 24 | $-0.58 | — | ||
| Q2 24 | $-0.34 | — | ||
| Q1 24 | $-1.32 | — | ||
| Q4 23 | $0.05 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
